Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

640 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X; Club Rhumatismes et Inflammations and the French Society of Rheumatology. Gottenberg JE, et al. Among authors: ravaud p. Ann Rheum Dis. 2013 Jun;72(6):1026-31. doi: 10.1136/annrheumdis-2012-202293. Epub 2012 Dec 21. Ann Rheum Dis. 2013. PMID: 23264337
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J. Mariette X, et al. Among authors: ravaud p. Arthritis Rheum. 2004 Apr;50(4):1270-6. doi: 10.1002/art.20146. Arthritis Rheum. 2004. PMID: 15077311 Free article. Clinical Trial.
Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis.
Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Pham T, et al. Among authors: ravaud p. Ann Rheum Dis. 2004 Dec;63(12):1611-7. doi: 10.1136/ard.2003.019703. Epub 2004 Aug 26. Ann Rheum Dis. 2004. PMID: 15331394 Free PMC article. Clinical Trial.
640 results